State of Wisconsin Investment Board
KLRS

State of Wisconsin Investment Board’s Kalaris Therapeutics KLRS Stock Holding History

State of Wisconsin Investment Board’s Portfolio KLRS Stock Details KLRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3,645
Closed -$180K – 2597
2023
Q3 		$180K Sell
3,645
-388
-10% -$26.4K ﹤0.01% 2269
2023
Q2 		$315K Sell
4,033
-2,399
-37% -$228K ﹤0.01% 1982
2023
Q1 		$583K Sell
6,432
-629
-9% -$80.1K ﹤0.01% 1802
2022
Q4 		$833K Sell
7,061
-1,346
-16% -$228K ﹤0.01% 1598
2022
Q3 		$1.53M Sell
8,407
-1,879
-18% -$293K ﹤0.01% 1410
2022
Q2 		$923K Buy
10,286
+6,208
+152% +$651K ﹤0.01% 1682
2022
Q1 		$633K Buy
4,078
+2,978
+271% +$594K ﹤0.01% 1740
2021
Q4 		$327K Hold
1,100
– – ﹤0.01% 1882
2021
Q3 		$634K Hold
1,100
– – ﹤0.01% 1610
2021
Q2 		$499K Hold
1,100
– – ﹤0.01% 1690
2021
Q1 		$592K Hold
1,100
– – ﹤0.01% 1540
2020
Q4 		$973K Buy
+1,100
New +$846K ﹤0.01% 1338

Other funds holding KLRS

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return

State of Wisconsin Investment Board's KLRS Position: Q4 2023 in Review

State of Wisconsin Investment Board sold out of Kalaris Therapeutics (KLRS) in Q4 2023, closing a stake of 3,645 shares — an estimated $180K sold.

State of Wisconsin Investment Board first reported a position in KLRS in Q4 2020 and held it in 12 quarters. The position peaked at $1.53M in Q3 2022. 81 funds tracked by Wall St. Rank hold KLRS as of Q4 2023.

  • State of Wisconsin Investment Board reported no remaining Kalaris Therapeutics position as of Q4 2023 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 3,645 Kalaris Therapeutics shares in Q4 2023, an estimated $180K.
  • State of Wisconsin Investment Board first reported a position in Kalaris Therapeutics in Q4 2020 and held it in 12 quarters.
  • State of Wisconsin Investment Board's Kalaris Therapeutics position peaked at $1.53M in Q3 2022.
  • 81 funds tracked by Wall St. Rank held Kalaris Therapeutics as of Q4 2023.

Based on State of Wisconsin Investment Board's 13F filing for Q4 2023, filed 12 Feb 2024.